Salivary testosterone measurement in women with and without polycystic ovary syndrome
Abstract Clinical and/or biochemical hyperandrogenism is one of the diagnostic criteria for PCOS. An evaluation of the role of salivary testosterone (salT) and androstenedione (salA) for the diagnosis of PCOS was undertaken in a cross sectional study involving 65 women without PCOS and 110 women wit...
Guardado en:
Autores principales: | , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/34fff71c18c34878864e74abc66742e5 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:34fff71c18c34878864e74abc66742e5 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:34fff71c18c34878864e74abc66742e52021-12-02T11:52:26ZSalivary testosterone measurement in women with and without polycystic ovary syndrome10.1038/s41598-017-03945-w2045-2322https://doaj.org/article/34fff71c18c34878864e74abc66742e52017-06-01T00:00:00Zhttps://doi.org/10.1038/s41598-017-03945-whttps://doaj.org/toc/2045-2322Abstract Clinical and/or biochemical hyperandrogenism is one of the diagnostic criteria for PCOS. An evaluation of the role of salivary testosterone (salT) and androstenedione (salA) for the diagnosis of PCOS was undertaken in a cross sectional study involving 65 women without PCOS and 110 women with PCOS fulfilling all 3 diagnostic Rotterdam criteria. Serum and salivary androgen measurements were determined by LC-MS/MS. salT and salA were significantly elevated in PCOS compared to controls (P < 001). No androgen marker was more predictive than another using ROC curves, but multiple logistic regression suggested salT was more predictive than free androgen index (FAI) (p < 0.01). The combination of salT or FAI identified 100% of PCOS women. PCOS women with both biochemical and clinical hyperandrogenism as opposed to clinical hyperandrogenism alone showed a metabolic phenotype (p < 0.05) and insulin resistance (p < 0.001). PCOS patients with an isolated elevated FAI showed increased insulin resistance compared to those with an isolated salT (P < 0.05). salT appeared to be at least as predictive as FAI for the diagnosis of the classical PCOS phenotype, and the combination of salT or FAI identified 100% of PCOS patients. This suggests that salT measurement by LC-MS/MS holds the promise of complementing existing laboratory tests as a means of assessing hyperandrogenemia.Thozhukat SathyapalanAhmed Al-QaissiEric S. KilpatrickSoha R. DarghamJoanne AdawayBrian KeevilStephen L. AtkinNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 7, Iss 1, Pp 1-9 (2017) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Medicine R Science Q |
spellingShingle |
Medicine R Science Q Thozhukat Sathyapalan Ahmed Al-Qaissi Eric S. Kilpatrick Soha R. Dargham Joanne Adaway Brian Keevil Stephen L. Atkin Salivary testosterone measurement in women with and without polycystic ovary syndrome |
description |
Abstract Clinical and/or biochemical hyperandrogenism is one of the diagnostic criteria for PCOS. An evaluation of the role of salivary testosterone (salT) and androstenedione (salA) for the diagnosis of PCOS was undertaken in a cross sectional study involving 65 women without PCOS and 110 women with PCOS fulfilling all 3 diagnostic Rotterdam criteria. Serum and salivary androgen measurements were determined by LC-MS/MS. salT and salA were significantly elevated in PCOS compared to controls (P < 001). No androgen marker was more predictive than another using ROC curves, but multiple logistic regression suggested salT was more predictive than free androgen index (FAI) (p < 0.01). The combination of salT or FAI identified 100% of PCOS women. PCOS women with both biochemical and clinical hyperandrogenism as opposed to clinical hyperandrogenism alone showed a metabolic phenotype (p < 0.05) and insulin resistance (p < 0.001). PCOS patients with an isolated elevated FAI showed increased insulin resistance compared to those with an isolated salT (P < 0.05). salT appeared to be at least as predictive as FAI for the diagnosis of the classical PCOS phenotype, and the combination of salT or FAI identified 100% of PCOS patients. This suggests that salT measurement by LC-MS/MS holds the promise of complementing existing laboratory tests as a means of assessing hyperandrogenemia. |
format |
article |
author |
Thozhukat Sathyapalan Ahmed Al-Qaissi Eric S. Kilpatrick Soha R. Dargham Joanne Adaway Brian Keevil Stephen L. Atkin |
author_facet |
Thozhukat Sathyapalan Ahmed Al-Qaissi Eric S. Kilpatrick Soha R. Dargham Joanne Adaway Brian Keevil Stephen L. Atkin |
author_sort |
Thozhukat Sathyapalan |
title |
Salivary testosterone measurement in women with and without polycystic ovary syndrome |
title_short |
Salivary testosterone measurement in women with and without polycystic ovary syndrome |
title_full |
Salivary testosterone measurement in women with and without polycystic ovary syndrome |
title_fullStr |
Salivary testosterone measurement in women with and without polycystic ovary syndrome |
title_full_unstemmed |
Salivary testosterone measurement in women with and without polycystic ovary syndrome |
title_sort |
salivary testosterone measurement in women with and without polycystic ovary syndrome |
publisher |
Nature Portfolio |
publishDate |
2017 |
url |
https://doaj.org/article/34fff71c18c34878864e74abc66742e5 |
work_keys_str_mv |
AT thozhukatsathyapalan salivarytestosteronemeasurementinwomenwithandwithoutpolycysticovarysyndrome AT ahmedalqaissi salivarytestosteronemeasurementinwomenwithandwithoutpolycysticovarysyndrome AT ericskilpatrick salivarytestosteronemeasurementinwomenwithandwithoutpolycysticovarysyndrome AT sohardargham salivarytestosteronemeasurementinwomenwithandwithoutpolycysticovarysyndrome AT joanneadaway salivarytestosteronemeasurementinwomenwithandwithoutpolycysticovarysyndrome AT briankeevil salivarytestosteronemeasurementinwomenwithandwithoutpolycysticovarysyndrome AT stephenlatkin salivarytestosteronemeasurementinwomenwithandwithoutpolycysticovarysyndrome |
_version_ |
1718395039227314176 |